Novo Nordisk expands US headquarters in Princeton, new Jersey
Novo Nordisk A/S, the world's largest maker of insulin, said Wednesday that it plans to expand its US headquarters in Princeton, New Jersey to accommodate future growth.
Novo Nordisk has announced plans to create a new corporate centre in Europe that will house its top management and improve its organisational efficiency.